App-Quantinova.ai

Retroperitoneal fibrosis patients need a dedicated multidisciplinary team

Evelyn Qian - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Ormond's disease

N/A

Management of adults with systemic lupus erythematosus (SLE) in 2021: a multi-centre audit within Wales as part of an ongoing quality improvement exercise

Sarah E Wright - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Why do rheumatologists request PET-CT scans and what do they show: an audit from a tertiary London Hospital

Kathryn Biddle - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Inpatient admission pathway for patients with rheumatological disorders

Andrea Hall - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Iloprost

An audit of demographics, symptoms & investigations: Part of the survey of GCA in the SEHSCT during the COVID-19 pandemic

Han Jun Tan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

An audit showing the successful operation of a nurse-led gout clinic during the COVID-19 pandemic

Lesley-Ann McWilliams - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Is there an urgent need to change the methotrexate monitoring guidelines to incorporate fibroscan?

Satheekshan Ramalingam - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory Arthritis

Methotrexate

I feel a bit happier about going on it now: exploring the information needs of people starting methotrexate

Sarah J Logan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Methotrexate

A review of MRI indications and outcomes to identify a clinical predictor for joint inflammation

Lucinda Barry - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Checkpoint inhibitor-induced rheumatological adverse events: real-world experience from Northeast England

Abigail Gault - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Anti-CTLA4

What information should we provide to inform and empower our patients to participate in shared decision making? The patient perspective

Nidhimol Mathews - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

An audit examining specialist referral for osteoporosis treatment for rheumatoid arthritis patients using new NOGG (National Osteoporosis Guideline Group) Guidelines 2022

Atif Rauf - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxyzine

Co-production of a quality improvement project to address glucocorticoid toxicity

Funmi Morgan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

Glucocorticoid

A case of ocular myasthenia gravis seen by rheumatology as suspected mononeuritis multiplex in an adult male shortly after Pfizer-BioNTech SARS-CoV-2 vaccination

Alice Storrie - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myasthenia gravis

N/A

Erosive psoriatic arthritis causing deafness

Alice K Coulton - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Raynaud syndrome

Hydroxychloroquine

ANCA-associated but not vasculitis

Vera Saulite - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

Methylprednisolone

COVID-19 vaccine-induced myositis

Luke Thompson - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Acute Leukemia

N/A

A case of RS3PE triggered by immune check point inhibitor

Deepak Ramachandran - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

Pembrolizumab

Pneumatosis intestinalis with spontaneous pneumoperitoneum in a patient with systemic sclerosis-myositis overlap syndrome: a case report and review of the literature

Kian Wah Lim - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

A rare case of coexistence of ANCA-associated vasculitis and malignancy

Sajeel Ahmed - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Anti-neutrophil cytoplasmic antibody-associated vasculitis

Prednisolone

Filters

45280 Abstracts